Rare diseases
Investigational molecules
Locations
Back to Italy157 clinical trials in Trieste, Italy across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study Comparing Anakinra and Prednisone for Children with Colchicine-Resistant Recurrent Pericarditis
ItalyStudy of Venetoclax, Ibrutinib, and Rituximab or Bendamustine Combination for Patients with Untreated Mantle Cell Lymphoma Not Suitable for High-Dose Therapy
ItalyStudy on Methotrexate and Dexamethasone for Infants Under One Year with Acute Lymphoblastic Leukemia
ItalyStudy on Tranexamic Acid and Sodium Chloride for Patients with Stroke-Related Brain Bleeding
ItalyStudy Comparing Mosunetuzumab and Lenalidomide with Other Treatments for Patients with Relapsed or Refractory Marginal Zone Lymphoma
ItalyStudy on the Effectiveness of Infliximab for Children with Inflammatory Bowel Disease
ItalyStudy on Early Drug Withdrawal in Children with Juvenile Idiopathic Arthritis Using Secukinumab and Drug Combination for Those in Clinical Remission
ItalyStudy on the Effects of Filgotinib for Children and Teenagers with Moderate to Severe Ulcerative Colitis
ItalyA Phase 2 Study Evaluating the Safety and Efficacy of Oral NS-863 in Adults with Pulmonary Hypertension Associated with Interstitial Lung Disease
ItalyPhase 2 Randomized Trial of Oral NS-863 in Patients with Pulmonary Arterial Hypertension
ItalySafety, Tolerability, and Preliminary Efficacy of Soquelitinib in Adults with Moderate to Severe Atopic Dermatitis (Phase 2 Study)
ItalyPhase II Study of Cemiplimab to Spare Surgery in Patients with Locally Advanced Cutaneous Squamous Cell Carcinoma
ItalyThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking research focusing on blood disorders and malignancies, including innovative treatments for leukemia and lymphoma. Clinical trials are evaluating new therapeutic combinations and targeted approaches.
Studies are exploring both chemotherapy-free alternatives and novel drug combinations to improve patient outcomes.
Advanced research into respiratory conditions, with a particular focus on progressive lung disorders. Studies are evaluating new therapeutic approaches for managing chronic conditions.
Trials aim to assess treatment efficacy through measurement of vital capacity and disease progression markers.
Comprehensive studies of various cancer types, incorporating innovative therapeutic approaches and targeted treatments. Focus on both rare and common malignancies.
Research emphasizes personalized medicine approaches and combination therapies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
